Self-Directed Review in GCRA - Bundle 4 | Hereditary Gastrointestinal Cancer Syndromes
Identifying hereditary cancer predisposition through genetic cancer risk assessment (GCRA) allows for intensified measures to prevent cancers or detect them at an earlier, more treatable stage. Once delivered primarily through academic health centers, the demand for GCRA services in the community setting is steadily increasing. There is a surge in demand for GCRA services across the nation, but too few clinicians with adequate training to provide GCRA services.
The increasing demand for GCRA services has been fueled by the rapid evolution of genetic information and direct-to-consumer marketing by commercial genetic testing vendors.
Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in Genetics or Advanced Practice Nurses, and Geneticists.
- Recognize the features of hereditary gastrointestinal and other cancers associated with Lynch Syndrome.
- Discuss the methods and limitations of tumor screening for Lynch syndrome.
- Identify the features and mode of inheritance of constitutional mismatch repair deficiency (CMMRD).
- Recognize the characteristics of familial colorectal cancer (CRC) type X.
- Identify the features distinguishing different hereditary polyposis syndromes.
- Recognize the association between polyp histology and potential germline genetic predisposition to a polyposis syndrome.
- Discern the features of different polyposis syndromes, including: Familial adenomatous polyposis; MutYH-associated polyposis; Hamartomatous Polyposis Syndromes; Serrated Polyposis Syndrome.
- Recognize the features of hereditary gastric cancers.
- Recognize the features of hereditary pancreatic cancers.
- Apply appropriate germline genetic testing strategies for hereditary gastrointestinal syndromes.
- Determine which cases of CRC have defective mismatch repair.
- Screen for Lynch Syndrome among newly diagnosed CRC & endometrial cancer (EC) patients.
- Discuss the Ohio State University clinical experience doing IHC on all newly diagnosed CRC & EC patients .
- Review evaluation of genomic applications in practice and prevention (EGAPP) recommendations.
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.
As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 24 months. Faculty presenters who are in a position to control the content of an educational activity must identify any real or apparent conflict(s) of interest by disclosing to the Department of CME all relevant financial relationships with any ineligible company, which is defined as any entity whose primary business is to produce, market , sell, re-sell or distribute healthcare products used by or on patients. To comply with more intense scrutiny by accreditation agencies, content whose faculty has disclosed any relevant financial relationships with an ineligible company, have been peer reviewed prior to presenting and any potential conflicts relative to the previous disclosure have been resolved.
Presenters/Planners: Listing of Faculty and respective Disclosures
The educational content has been peer-reviewed, an attestation on file and no conflicts were noted.
CME Committee/Reviewer Nothing to Disclose: Daneng Li, MD
City of Hope further encourages faculty/ authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.
The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.
This activity has received no commercial support.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this enduring activity for a maximum of 3.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 3.5
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 3.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 3.50 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this Self-Directed Review in GCRA - Bundle 4 | Hereditary Gastrointestinal Cancer Syndromes for a maximum of 3.50 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.50 Attendance